In particular, the deterioration of metabolic health is often accompanied by a cascade of metabolic disturbances—such as insulin resistance, ectopic fat accumulation, and dyslipidemia—that act synergistically to elevate the risk of cardiovascular and metabolic diseases substantially. The gene discussed is INS; the disease is metabolic disease.